{"id":189520,"name":"THE UNITED STATES PHARMACOPEIAL CONVENTION","slug":"the-united-states-pharmacopeial-convention","state":"MD","country":"United States of America","description":"","totalSpending":2650000,"filings":32,"yearlySpending":[{"year":2018,"income":270000},{"year":2019,"income":450000},{"year":2020,"income":420000},{"year":2021,"income":370000},{"year":2022,"income":320000},{"year":2023,"income":220000},{"year":2024,"income":240000},{"year":2025,"income":360000}],"issues":[{"code":"PHA","display":"Pharmacy"},{"code":"HCR","display":"Health Issues"},{"code":"BUD","display":"Budget/Appropriations"},{"code":"DEF","display":"Defense"}],"firms":["THE UNITED STATES PHARMACOPEIAL CONVENTION"],"lobbyists":["CARRIE HARNEY","JOSEPH HILL","TIMOTHY CASEY"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE","Health & Human Services, Dept of (HHS)"],"sampleDescriptions":["S.2315, Over-the-Counter Drug Safety, Innovation, and Reform Act; \n\nOver-the-counter reform;\n\nRole of USP monographs in FDAs OTC monograph system;\n\nFDA appropriations; role of quality standards;\n\nThe ","H.R. 5687, SOUND Disposal and Packaging Act; provisions related to FDA packaging and disposal. \n\nFDA appropriations; role of quality standards;\n\nUSP work on opioids;","HR 6, SUPPORT for Patients and Communities Act; provisions related to opioids. \n\nPotential role of compendial standards for packaging","HR 1959, To amend the Federal Food, Drug, and Cosmetic Act with respect to compounding pharmacies, and for other purposes; all provisions","2020 Budget, specifically provisions related to encouraging Biosimilar Development"]}